In: Nelson Textbook of Pediatrics | Xeljanz, Xeljanz XR tofacitinib : Drug safety communication — Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulcerative colitis medicine |
---|---|
Epidemiology, pathogenesis, and diagnosis of inflammatory bowel diseases | The facts about inflammatory bowel diseases |
Surveillance and management of dysplasia in patients with inflammatory bowel disease.
In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management | |
---|---|
.